First patient dosed in COVID-19 trial with allogeneic cell therapy
The first patient with COVID-19 has been administered agenT-797, an allogeneic cell therapy…
The first patient with COVID-19 has been administered agenT-797, an allogeneic cell therapy made by Agenus Inc.